
Executive Editor, Endpoints News (@endpts). Got a confidential tip? Message me on Signal: DrewArmstrong.39
NYC
Joined October 2009
- Tweets10.1K
- Following3.1K
- Followers28.9K
- Likes10.8K
Drew Armstrong retweeted
Scoop: Sanofi is exploring a potential takeover of Insmed, sources say, in what could be the biggest biopharma deal since Pfizer bought Seagen for $43 billion back in 2023.
bloomberg.com/news/articles/…
Drew Armstrong retweeted
Endpoints News reporting that WH CoS Stephen Miller played a direct role in Overton's nomination being pulled (which most folks probably assumed, but this reporting reinforces).
Hard to imagine that Heidi Overton will remain on the WH Domestic Policy Council after this.
endpoints.news/how-trump-fda…
politico.com/news/2026/11/06…
This is going to have reverberations throughout government.
Drew Armstrong retweeted
Replying to @maxonwifi @endpts
Allies of Overton knew it'd be close, but thought she'd corral enough support in the Senate. So did @SenBillCassidy. But behind the scenes, senior HHS officials were pushing the White House to pull her nomination, part of a coordinated campaign that began when Susie Wiles left.
Drew Armstrong retweeted
An @endpts exclusive: Inside Heidi Overton's failed FDA nomination, and the new, powerful White House-MAHA alliance that tanked it.
endpoints.news/how-trump-fda…
Drew Armstrong retweeted
EXCLUSIVE: Boltz says pharma usage of its AI drug design software is up 50x, raising a $110M Series A to double down and expand, @GabriCorso tells me
My latest for @endpts on another major AI bio raise in London: endpoints.news/ai-bio-startu…
Pretty astounding compared to the other options:
Are you a New Yorker and want to be a journalist? CUNY's Newmark J-School is now tuition-free for all New York state residents.
Proud to teach here.
journalism.cuny.edu/future-s…
Pretty astounding compared to the other options:
Are you a New Yorker and want to be a journalist? CUNY's Newmark J-School is now tuition-free for all New York state residents.
Proud to teach here.
journalism.cuny.edu/future-s…
4
1,555
The WH appears to have yanked Overton's nom while their biggest potential obstacle was trying to get her across the line.... (admittedly, Cassidy has a history of over-optimism about all things health appointee)
Tonight, the White House abandoned a viable confirmation path for Dr. Overton. The WH said that this was because she did not have the votes to pass. This was odd as I was having productive conversations with members. I believe she would have had the votes to pass out of committee and pass the full Senate. My conversations with her convinced me she would follow the science and push back against decisions that put Americans’ health at risk. The last issue was that pro-life Senators sought final assurances from the Administration regarding the Administration’s commitment to life issues. The Administration withdrew Dr. Overton rather than make such commitments. Unfortunately, with the limited time left, confirming a permanent FDA Commissioner will fall to Senate Democrats.
Updated story here: endpoints.news/white-house-p…
2
764
It's Over-ton. (From @maxonwifi )
endpoints.news/white-house-p…
Drew Armstrong retweeted
Three thoughts on $5B: What matters most about Isomorphic's historic raise
My latest for @endpts both on Isomorphic establishing itself as a biotech force, as well as diving into what comes next with its closely watched pipeline:
endpoints.news/analysis-3-th…
We're hiring!
📣 We're hiring at @endpts!
We're looking for a business of science reporter to cover breaking news across biotech, digging into the advanced therapies and technologies that will lead to the drugs of tomorrow.
ats.rippling.com/endpointsne…
5
1,658
📣 We're hiring at @endpts!
We're looking for a business of science reporter to cover breaking news across biotech, digging into the advanced therapies and technologies that will lead to the drugs of tomorrow.
ats.rippling.com/endpointsne…
Are you a sciency, scoop-loving and business-savvy reporter? We'd love to know about you.
We're an award-winning, work-from-anywhere newsroom with a phenomenal team of reporters and editors.
Got somebody we should pursue? DM me.
ats.rippling.com/endpointsne…
2
862
Drew Armstrong retweeted
a good argument for why spokespeople should be pushed to put their names on company statements
nitter.gq/ShakeelHashim/status/2…
















